Utpal Dave
Faculty Member
Last active: 2/22/2016

  1. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding. Layer JH, Alford CE, McDonald WH, Davé UP (2016) Mol Cell Biol 36(3): 488-506
    › Primary publication · 26598604 (PubMed) · PMC4719424 (PubMed Central)
  2. Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation. Triplett TA, Cardenas KT, Lancaster JN, Hu Z, Selden HJ, Jasso GJ, Balasubramanyam S, Chan K, Li L, Chen X, Marcogliese AN, Davé UP, Love PE, Ehrlich LI (2016) Proc Natl Acad Sci U S A 113(8): E1016-25
    › Primary publication · 26862168 (PubMed) · PMC4776467 (PubMed Central)
  3. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. McGirt LY, Jia P, Baerenwald DA, Duszynski RJ, Dahlman KB, Zic JA, Zwerner JP, Hucks D, Dave U, Zhao Z, Eischen CM (2015) Blood 126(4): 508-19
    › Primary publication · 26082451 (PubMed) · PMC4513251 (PubMed Central)
  4. Hhex is Required at Multiple Stages of Adult Hematopoietic Stem and Progenitor Cell Differentiation. Goodings C, Smith E, Mathias E, Elliott N, Cleveland SM, Tripathi RM, Layer JH, Chen X, Guo Y, Shyr Y, Hamid R, Du Y, Davé UP (2015) Stem Cells 33(8): 2628-41
    › Primary publication · 25968920 (PubMed) · PMC4641572 (PubMed Central)
  5. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias. Goodings C, Tripathi R, Cleveland SM, Elliott N, Guo Y, Shyr Y, Davé UP (2015) Leuk Res 39(1): 100-9
    › Primary publication · 25499232 (PubMed) · PMC4277943 (PubMed Central)
  6. LMO2 induces T-cell leukemia with epigenetic deregulation of CD4. Cleveland SM, Goodings C, Tripathi RM, Elliott N, Thompson MA, Guo Y, Shyr Y, Davé UP (2014) Exp Hematol 42(7): 581-93.e5
    › Primary publication · 24792354 (PubMed) · PMC4241760 (PubMed Central)
  7. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways. Smith S, Tripathi R, Goodings C, Cleveland S, Mathias E, Hardaway JA, Elliott N, Yi Y, Chen X, Downing J, Mullighan C, Swing DA, Tessarollo L, Li L, Love P, Jenkins NA, Copeland NG, Thompson MA, Du Y, Davé UP (2014) PLoS One 9(1): e85883
    › Primary publication · 24465765 (PubMed) · PMC3897537 (PubMed Central)
  8. Tgif1 regulates quiescence and self-renewal of hematopoietic stem cells. Yan L, Womack B, Wotton D, Guo Y, Shyr Y, Davé U, Li C, Hiebert S, Brandt S, Hamid R (2013) Mol Cell Biol 33(24): 4824-33
    › Primary publication · 24100014 (PubMed) · PMC3889555 (PubMed Central)
  9. Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Cleveland SM, Smith S, Tripathi R, Mathias EM, Goodings C, Elliott N, Peng D, El-Rifai W, Yi D, Chen X, Li L, Mullighan C, Downing JR, Love P, Davé UP (2013) Stem Cells 31(5): 882-94
    › Primary publication · 23378057 (PubMed) · PMC3652616 (PubMed Central)
  10. Targeting nonclassical oncogenes for therapy in T-ALL. Subramaniam PS, Whye DW, Efimenko E, Chen J, Tosello V, De Keersmaecker K, Kashishian A, Thompson MA, Castillo M, Cordon-Cardo C, Davé UP, Ferrando A, Lannutti BJ, Diacovo TG (2012) Cancer Cell 21(4): 459-72
    › Primary publication · 22516257 (PubMed)